285 related articles for article (PubMed ID: 31243641)
1. Effects of Macuprev
Parravano M; Tedeschi M; Manca D; Costanzo E; Di Renzo A; Giorno P; Barbano L; Ziccardi L; Varano M; Parisi V
Adv Ther; 2019 Sep; 36(9):2493-2505. PubMed ID: 31243641
[TBL] [Abstract][Full Text] [Related]
2. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
3. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
[TBL] [Abstract][Full Text] [Related]
4. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
6. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
8. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
[TBL] [Abstract][Full Text] [Related]
10. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
[TBL] [Abstract][Full Text] [Related]
11. Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT.
Yang S; Zuo C; Xiao H; Mi L; Luo G; Xu X; Liu X
Doc Ophthalmol; 2016 Feb; 132(1):17-26. PubMed ID: 26754967
[TBL] [Abstract][Full Text] [Related]
12. The effect of nutritional supplementation on the multifocal electroretinogram in healthy eyes.
Berrow EJ; Bartlett HE; Eperjesi F
Doc Ophthalmol; 2016 Apr; 132(2):123-35. PubMed ID: 26988845
[TBL] [Abstract][Full Text] [Related]
13. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
Wolf-Schnurrbusch UE; Zinkernagel MS; Munk MR; Ebneter A; Wolf S
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8069-74. PubMed ID: 26720458
[TBL] [Abstract][Full Text] [Related]
14. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
15. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
16. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
[TBL] [Abstract][Full Text] [Related]
17. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
18. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.
Piermarocchi S; Saviano S; Parisi V; Tedeschi M; Panozzo G; Scarpa G; Boschi G; Lo Giudice G;
Eur J Ophthalmol; 2012; 22(2):216-25. PubMed ID: 22009916
[TBL] [Abstract][Full Text] [Related]
19. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.
Murray IJ; Makridaki M; van der Veen RL; Carden D; Parry NR; Berendschot TT
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1781-8. PubMed ID: 23385792
[TBL] [Abstract][Full Text] [Related]
20. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
